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he Tie1 receptor tyrosine kinase was isolated over a
decade ago, but so far no ligand has been found to
activate this receptor. Here, we have examined the
potential of angiopoietins, ligands for the related Tie2
receptor, to mediate Tie1 activation. We show that a
soluble Ang1 chimeric protein, COMP-Ang1, stimulates
Tie1 phosphorylation in endothelial cells with similar kinetics
and angiopoietin dose dependence when compared with
Tie2. The phosphorylation of overexpressed Tie1 was
weakly induced by COMP-Ang1 also in transfected cells
T
 
that do not express Tie2. When cotransfected, Tie2 formed
heteromeric complexes with Tie1, enhanced Tie1 activation,
and induced phosphorylation of a kinase-inactive Tie1 in a
ligand-dependent manner. Tie1 phosphorylation was also
induced by native Ang1 and Ang4, although less efﬁ-
ciently than with COMP-Ang1. In conclusion, we show that
Tie1 phosphorylation is induced by multiple angiopoietin
proteins and that the activation is ampliﬁed via Tie2. These
results should be important in dissecting the signal trans-
duction pathways and biological functions of Tie1.
 
Introduction
 
Tie1, an endothelial-specific receptor tyrosine kinase, shares
a high degree of homology with Tie2, the receptor for the
angiopoietins (Yancopoulos et al., 2000; Jones et al., 2001;
Peters et al., 2004). The expression of the 
 
Tie1
 
 gene is restricted
to endothelial cells and to some hematopoietic cell lineages
(Partanen et al., 1992; Korhonen et al., 1994; Dumont et al., 1995;
Hashiyama et al., 1996; Yano et al., 1997). Up-regulation of
Tie1 expression has been observed during wound healing,
ovarian follicle maturation, and tumor angiogenesis (Korhonen
et al., 1992; Kaipainen et al., 1994).
Targeted disruption of the mouse 
 
Tie1
 
 gene results in
embryonic lethality after embryonic day (E) 13.5 because of
severe edema, hemorrhages, and defective microvessel integrity
(Puri et al., 1995; Sato et al., 1995). Tie1 is required cell auton-
omously for endothelial cell survival and extension of the
vascular network during late embryogenesis, particularly in
regions undergoing angiogenic growth of capillaries (Puri et
al., 1995; Sato et al., 1995). Tie2 knockout mouse embryos die
by E10.5 due to endocardial defects, hemorrhaging, and im-
paired vascular network formation (Dumont et al., 1994; Sato
et al., 1995). Embryos lacking both Tie1 and Tie2 revealed an
absolute requirement for Tie2 in the endocardium at E10.5,
whereas both receptors were dispensable for the initial assembly
of the rest of the vasculature (Puri et al., 1999). In contrast,
both receptors were required in the microvasculature during
late organogenesis, in essentially all blood vessels of the
adult and for postnatal bone marrow hematopoiesis (Puri and
Bernstein, 2003).
Although Tie1 is an orphan receptor with no known
ligands, three members of the angiopoietin family (Ang1,
Ang2, and Ang3/4) have been identified as ligands for Tie2
(Lee et al., 2004; Peters et al., 2004). Ang1 promotes vascular
remodeling, maturation, and stabilization of the vasculature,
and the Ang1 null phenotype is very similar to the Tie2 null
phenotype resulting in embryonic lethality at E12.5 (Suri et al.,
1996). Overexpression of Ang2 in the blood vessels mimicked
the phenotype of Tie2 null embryos and led to lethality at
E9.5–10.5 (Maisonpierre et al., 1997), suggesting an antagonist
function for Ang2 in Tie2 signaling. In endothelial cells, Ang1
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induced Tie2 phosphorylation, whereas Ang2 did not (Maison-
pierre et al., 1997), unless the cells were treated for a prolonged
period (Teichert-Kuliszewska et al., 2001). To date, none of the
angiopoietins have been shown to induce Tie1 activation.
Without a ligand, the signal transduction pathway down-
stream of Tie1 activation and responsible for its biological
function has been difficult to elucidate. However, experiments
using a chimeric receptor composed of the extracellular do-
main of colony-stimulating factor-1 receptor and the intracellu-
lar domain of Tie1 showed that activated Tie1 associates with
the phosphatidylinositol 3-kinase, resulting in activation of the
serine/threonine kinase Akt (Kontos et al., 2002). This result
protected cells from apoptosis, indicating overlapping func-
tions of Tie1 and Tie2 (Kontos et al., 1998).
Here, we have reassessed the possibility that the an-
giopoietins may affect Tie1 function. We show that a chimeric
Ang1 protein, native Ang1, and Ang4 induced Tie1 phosphory-
lation in primary and immortalized endothelial cells. Chimeric
Ang1 induced weak phosphorylation of Tie1 overexpressed in
nonendothelial cells, and this activation was enhanced by Tie2
coexpression. Furthermore, we demonstrate heteromeric Tie1–
Tie2 complexes in cells expressing both receptors. Our results
suggest that Ang1 and Ang4 proteins can activate Tie1 and that
Tie2 significantly amplifies the activation.
 
Results and discussion
 
COMP-Ang1 induces tyrosine 
phosphorylation of Tie1 in endothelial cells
 
To investigate the signal transduction pathways of Tie1, we
stimulated human dermal blood vascular endothelial cells
(BEC) and lymphatic endothelial cells (LEC; Makinen et al.,
2001) with the COMP-Ang1 chimeric protein (Cho et al.,
2004a,b). Surprisingly, COMP-Ang1 induced tyrosine phos-
phorylation of Tie1, in addition to phosphorylation of Tie2
(Fig. 1, A and B). Phosphorylation of Tie1 occurred in endo-
thelial cells within 5 min of COMP-Ang1 stimulation, reaching
a maximum level at 1 h, followed by a gradual down-regulation
(Fig. 1 C). The kinetics of Tie2 phosphorylation paralleled
these changes. Significant phosphorylation occurred with 100
ng/ml COMP-Ang1, but maximal phosphorylation of both re-
ceptors required 600 ng/ml (Fig. 1 D).
COMP-Ang1 induced phosphorylation of Tie1 and Tie2
also in the hybrid endothelial cell line EA.hy926 (Fig. 2 A).
In contrast, 600 ng/ml Ang2 did not activate either Tie1 or
Tie2. In fact, decreased Tie1 phosphorylation was seen when
COMP-Ang1 was provided in combination with an excess of
Ang2 (unpublished data).
The soluble extracellular domain of Tie2 (Tie2-Fc) has
been found to bind Ang1 and to inhibit Ang1 induced Tie2 ac-
tivation, whereas no effect has been found with the soluble
Tie1 receptor (Davis et al., 1996; Peters et al., 2004). Tie2-Fc
inhibited COMP-Ang1–induced Tie1 and Tie2 phosphoryla-
tion (Fig. 2 B), whereas Tie1-Fc had little if any effect, indicat-
ing that COMP-Ang1 binds to the soluble form of Tie2 but not
to soluble Tie1, although COMP-Ang1 was capable of induc-
ing activation of Tie1 at the cell surface.
 
COMP-Ang1 induces Tie1 phosphorylation, 
which is enhanced by Tie2
 
To understand the mechanism of COMP-Ang1–induced Tie1 ac-
tivation, we overexpressed Tie1 in 293T cells, which lack both
Tie1 and Tie2 (Fig. 3 A). Variable and low levels of Tie1 tyro-
Figure 1. COMP-Ang1 induces tyrosine phosphorylation of Tie1 in endo-
thelial cells. (A and B) Isolated BECs (A) and LECs (B) were starved over-
night and stimulated with COMP-Ang1 for 15 min or left unstimulated. The
cell lysates were immunoprecipitated with anti-Tie1 or anti-Tie2 antibodies.
Aliquots of the immunoprecipitates were separated by SDS-PAGE and
immunoblotted with antiphosphotyrosine, anti-Tie1, or anti-Tie2 antibodies.
Relative mobilities of the molecular mass markers are indicated in kilo-
daltons. (C) HMEC-1 cells were stimulated with COMP-Ang1 for the indi-
cated times followed by analysis of Tie1 and Tie2 as explained in A.
The chemiluminescence signal was quantitated using Fluorchem digital
imaging system (Flowgen Bioscience). Shown is relative phosphotyrosine
intensity normalized to Tie1 or Tie2 protein levels. (D) HMEC-1 cells were
stimulated with indicated amounts of COMP-Ang1 for 30 min followed by
analysis of Tie1 and Tie2 as in C. The results are shown as a percentage
of maximal receptor phosphorylation.
Figure 2. Soluble Tie2 receptor inhibits COMP-Ang1–induced Tie1 phos-
phorylation. (A) EA.hy926 cells were stimulated with COMP-Ang1 or
Ang2 or left unstimulated, followed by immunoprecipitation and analysis
of Tie1 and Tie2, as in Fig. 1. White line indicates that intervening lanes
have been spliced out. (B) EA.hy926 cells were stimulated with COMP-
Ang1 alone or in combination with 10  g/ml of soluble Tie1-Fc or Tie2-Fc
for 15 min. As a control, cells were treated with soluble Tie receptors only.
Tie1 and Tie2 were analyzed as in Fig. 1. 
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sine phosphorylation were detected after stimulation of these
cells with 600 ng/ml COMP-Ang1 (Fig. 3 B). This finding sug-
gested that overexpressed Tie1 can be activated to some degree
by high concentrations of COMP-Ang1 in the absence of Tie2.
Next, we examined the effect of Tie2 on Tie1 activation
by COMP-Ang1 in the transfected cells. Because of the strong
basal autophosphorylation of Tie2 in 293T cells (unpublished
data), we used 293 cells that do not replicate transiently trans-
fected expression plasmids. 293 cells were transfected with
vectors encoding Tie1, Tie2, or both and stimulated with
COMP-Ang1. COMP-Ang1–induced tyrosine phosphoryla-
tion of Tie1 was increased in the double transfected cells in
comparison with cells transfected only with Tie1, suggesting
that heteromerization of Tie1 and Tie2 enhances Tie1 activa-
tion (Fig. 3 C). In contrast, Tie2 phosphorylation was not en-
hanced by the presence of Tie1 when compared with cells
transfected with Tie2 alone.
It was possible that Tie2 was required for high-affinity
binding of COMP-Ang1 to Tie1 or that Tie2 induced the phos-
phorylation and thereby enhanced the activation of Tie1 in a
Tie1–Tie2 complex. To analyze this hypothesis, we expressed
K870R-Tie1 that has an inactivating substitution in the kinase
domain with or without Tie2 (Fig. 3 D). K870R-Tie1 was
phosphorylated in a ligand-dependent manner when coex-
pressed with Tie2, whereas no phosphorylation was detected in
the absence of Tie2. Thus, Tie2 was able to induce Tie1 phos-
phorylation.
We also tested if a kinase-inactive K855R-Tie2, like
wild-type Tie2, was able to enhance Tie1 phosphorylation.
However, we found that Tie1 phosphorylation was reduced
when it was coexpressed with K855R-Tie2 (Fig. 3 E), indicat-
ing that the kinase activity of Tie2 is required for full enhance-
ment of Tie1 activation by COMP-Ang1.
 
Tie1 forms a heteromeric complex with 
Tie2
 
The results obtained from the transfected cells suggested that
Tie1 and Tie2 undergo heteromerization when stimulated by
COMP-Ang1. To analyze this finding, we used 293T cells
transfected with Tie1-V5 and Tie2-Myc constructs. After
COMP-Ang1 stimulation, the cell surface proteins were chemi-
cally cross-linked with 3,3
 
 
 
-dithiobis[sulfosuccinimidylpropi-
onate] (DTSSP), a membrane nonpermeable cross-linker, and
Tie1 was immunoprecipitated from the cell lysates. Interest-
ingly, Tie2 was coprecipitated with Tie1 from the double trans-
fected cells (Fig. 4 A). The treatment of human umbilical vein
endothelial cells (HUVECs) with DTSSP resulted in coprecipi-
tation of Tie1 with Tie2, whereas no coprecipitation was found
in nontreated cells (Fig. 4 B). In conclusion, Tie1 and Tie2
form heteromeric complexes on the cell surface.
In line with these results, Marron et al. (2000) have re-
ported interaction between the intracellular domains of the two
Tie receptors using the TrkA ectodomain fused to the Tie1 or
Tie2 endodomain. However, until now there was no evidence
that angiopoietins could induce Tie1 activation or heteromeric
Tie1–Tie2 complexes. Our results also suggest that in the het-
eromeric complexes Tie2 directly phosphorylates Tie1, as Tie2
induced phosphorylation of kinase-inactive Tie1 in a COMP-
Ang1–dependent manner.
COMP-Ang1 has been shown to be a more potent an-
giopoietin ligand than native Ang1 (Cho et al., 2004a,b). We
analyzed if also native Ang1 can induce Tie1 phosphorylation.
Figure 3. COMP-Ang1–induced Tie1 phos-
phorylation is enhanced by Tie2. (A) The ex-
pression of human Ang1, Ang2, Tie1, and
Tie2 was analyzed using Northern blotting of
total RNA from the cell lines indicated. White
lines indicate that intervening lanes have been
spliced out. (B) 293T cells were transfected
with Tie1 expression vector, as indicated, and
stimulated or not with COMP-Ang1. Tie1 was
analyzed as in Fig. 1. (C) 293 cells were
transfected with expression plasmids for Tie1
and Tie2, as indicated, followed by analysis
of Tie1 and Tie2 as in Fig. 1. (D) 293T cells
were transfected with expression plasmids for
wild-type or kinase-inactive Tie1 (K870R-Tie1)
and Tie2, as indicated, followed by analysis
of Tie1 as in Fig. 1. (E) 293 cells were trans-
fected with expression plasmids for Tie1 and
wild-type or kinase-inactive Tie2 (K855R-Tie2),
followed by analysis of Tie1 as in Fig. 1.
Figure 4. Tie1 and Tie2 interact at the cell surface. (A) 293T cells were
transfected with Tie1-V5 or Tie2-Myc expression plasmids, as indicated.
The cells were stimulated with COMP-Ang1 or left unstimulated, followed
by chemical cross-linking of the cell surface proteins with DTSSP. Tie1 was
immunoprecipitated using anti-V5 antibodies and analyzed as in Fig.1.
(B) HUVECs were treated with control vehicle or DTSSP, followed by Tie2
immunoprecipitation. The immunoprecipitates and cell lysates were separated
in SDS-PAGE and immunoblotted with anti-Tie2 and anti-Tie1 antibodies. 
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As shown in Fig. 5 A, native Ang1 induced Tie1 phosphoryla-
tion in endothelial cells, although severalfold less efficiently
than COMP-Ang1. In contrast, COMP-HFARP (hepatic fibrin-
ogen/angiopoietin-related protein) that does not bind to Tie1 or
Tie2 (Kim et al., 2000) had no effect even at high concentra-
tions. Thus, COMP-Ang1–induced Tie1 activation is mediated
via Ang1 and not by the COMP domain. In addition to Ang1,
Ang4 provides a ligand for human Tie2, whereas Ang3 is a
specific ligand for murine Tie2 (Lee et al., 2004). We found
that Tie1 phosphorylation was induced by native Ang4 but not
by Ang3 or Ang2 (Fig. 5 A).
We show here that Tie1 is activated in cells stimulated by
COMP-Ang1, a highly soluble and active form of human Ang1
that binds to Tie2 and forms mainly pentamers as compared
with trimers, tetramers, and high order multimers formed by
native Ang1 (Cho et al., 2004a,b). Tie1 phosphorylation has
also been detected in BOW-Ang1-treated rat endothelial cells
(Papadopoulos, N., and G. Thurston, personal communication).
Because of the poor solubility of the multimeric Ang1 growth
factor, the vast majority of published work has been conducted
with an Ang2/Ang1 chimeric protein called Ang1* (Koblizek
et al., 1998). Like Ang1*, COMP-Ang1 has an intact COOH-
terminal receptor binding domain, but includes a coiled coil do-
main distinct from the multimerization and coiled coil domains
that occupy the NH
 
2
 
 terminus of native Ang1 (Cho et al.,
2004a,b). However, despite the lower specific activity of native
angiopoietin ligands, we found that Ang1 and Ang4 can also
activate Tie1; likewise these ligands are known to activate hu-
man Tie2 (Lee et al., 2004).
Variable, low levels of Tie1 phosphorylation were in-
duced by COMP-Ang1 also in cells overexpressing Tie1 but
lacking Tie2. This finding was surprising as Ang1, Ang1*, or
COMP-Ang1 do not interact with the soluble Tie1-Fc re-
ceptor (Davis et al., 1996; Cho et al., 2004a; Peters et al.,
2004). In line with these results, Tie1-Fc was unable to in-
hibit COMP-Ang1–induced Tie1 phosphorylation (our present
data). It is possible that the overexpressed Tie1 has a very
weak affinity to the Ang1 receptor-binding domain and that
membrane association of Tie1 is required to enhance its bind-
ing to Tie1, as shown for ligand binding to erbB2 (Tzahar et
al., 1997). Ang1 could also induce a conformational change
in Tie1, thereby enhancing its affinity for Ang1, which could
not be mimicked by the soluble Tie1 extracellular domain.
Alternatively, COMP-Ang1–induced Tie1 activation could
involve complex formation with additional molecules, such
as integrins, with which Ang1 has been shown to interact
(Carlson et al., 2001). Although the details of how Ang1 and
Ang4 interact with Tie1 remains to be worked out, these an-
giopoietins can clearly activate the Tie1 receptor. These data
are consistent with studies showing that the phenotype of the
Tie1/Tie2 double knockout mice is more severe than that of
the Tie1 or Tie2 single knockouts (Partanen and Dumont,
1999; Peters et al., 2004). Our results on Ang1-induced Tie1
activation now call for a better understanding of the complex
biological signaling of Ang1 via the two Tie receptors in an-
giogenesis, lymphangiogenesis, and hematopoiesis.
 
Materials and methods
 
Reagents and cell culture
 
293, 293T (American Type Culture Collection), and EA.hy926 immortal-
ized hybrid HUVECs (Edgell et al., 1983) were grown in DME supple-
mented with 10% FBS (PromoCell). HUVECs were cultured as described
previously (Marron et al., 2000). LEC, BEC (Makinen et al., 2001), and
HMEC-1 human dermal microvascular cells immortalized with SV40 Large T
antigen (Ades et al., 1992) were grown in Endothelial Cell Basal Medium
(PromoCell) with supplements provided by the manufacturer. Confluent
plates of cells were serum-starved overnight, followed by ligand stimulation
for 15 min, unless otherwise indicated. The following reagents were used:
Tie1-Fc, Tie2-Fc, Ang1, VEGF (all from R&D Systems), Ang2, Ang3, Ang4
(Lee et al., 2004), COMP-HFARP (Kim et al., 2000), and Ang2 (Scharpfe-
necker et al., 2005). The following antibodies were used: antiphosphoty-
rosine (4G10; Upstate Biotechnology), anti-Tie1 and anti-Tie2 (R&D Sys-
tems; Santa Cruz Biotechnology, Inc.; clone 33 [Upstate Biotechnology]),
anti-V5 (Invitrogen), and anti-Tie2 (Harris et al., 2001).
 
DNA constructs and transfection
 
Cells were transfected using Fugene6 (Roche Diagnostics), changed to se-
rum-free medium after 48 h, and harvested 72 h after transfection. Kinase-
inactivating mutation in human Tie2 (lysine 855 to arginine), human Tie1
(lysine 870 to arginine), Tie1-V5, and Tie2-Myc constructs were created by
PCR. All constructs were confirmed by sequencing (Applied Biosystems).
 
Immunoprecipitation and immunoblotting
 
Cells were lysed in lysis buffer (50 mM Hepes, pH 7.5, 1% Triton X-100,
5% glycerol, 1 mM EGTA, 150 mM NaCl, 1.5 mM MgCl
 
2
 
, 100 mM
NaF, 1 mM Na
 
3
 
VO
 
4
 
, PMSF, aprotinin, and leupeptin) or alternatively in
SDS-lysis buffer (Saharinen et al., 1997). Equal amounts of cell lysate pro-
tein were precleared by incubation with protein G–Sepharose (Amersham
Biosciences), followed by addition of BSA (1%) and specific antibodies.
The immunocomplexes, captured by protein G–Sepharose, were sepa-
rated in 7.5% SDS-PAGE (Ready-Gels; Bio-Rad Laboratories) and blotted
and detected using specific primary antibodies, biotinylated anti–mouse
or anti–goat secondary antibodies (DakoCytomation), and streptavidin-
biotin HRP conjugate (Amersham Biosciences) followed by ECL detection
with the SuperSignal West Femto Maximun Sensitivity Substrate (Pierce
Chemical Co.).
HUVECs were cross-linked in PBS containing 0.5 mM DTSSP for 30
min, quenched by addition of Tris, pH 7.5, to 100 mM, and lysed in 50
mM Tris, pH 7.4, 50 mM NaCl, 1% Triton X-100, 1mM sodium orthovan-
adate, 1 mM sodium fluoride, 1 mM EGTA, and complete protease inhib-
itor. 293T cells were cross-linked for 40 min with 1 mM DTSSP on ice.
 
RNA isolation and Northern blotting
 
Total RNA was isolated using the RNeasy kit (QIAGEN), electrophoresed,
blotted, and hybridized with 
 
32
 
P-labeled cDNA probes.
Figure 5. Native Ang1 and Ang4, but not Ang2 or
Ang3, induce Tie1 phosphorylation. (A and B)
EA.hy926 cells were stimulated with indicated
amounts of COMP-Ang1, native Ang1, Ang2, Ang3,
Ang4, or COMP-HFARP or left unstimulated, followed
by immunoprecipitation and analysis as in Fig. 1. 
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